Your payment is in progress...
  +1 (704) 266-3234

Global Generic Drugs Market Growth 2020-2025

Published on: Sep 2020 | From USD $3660 | Published By: LP INFORMATION INC. | Number Of Pages: 167

According to this study, over the next five years the Generic Drugs market will register a 10.4%% CAGR in terms of revenue, the global market size will reach $ 373670 million by 2025, from $ 251790 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Generic Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Generic Drugs, covering the supply chain analysis, impact assessment to the Generic Drugs market size growth rate in several scenarios, and the measures to be undertaken by Generic Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Simple Generic Drugs
Super Generic Drugs
Biosimilars

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Lupin
Novartis - Sandoz
Sun Pharmaceutical
Aspen
Mylan
Sanofi
Fresenius Kabi
Aurobindo
Pfizer (Hospira)
Krka Group
Valeant
Nichi-Iko Pharmaceutical
Dr. Reddy's
ENDO (Par Pharmaceutical)
Cipla
Hikma
Stada Arzneimittel
Apotex
Zydus Cadila

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Generic Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Generic Drugs market by identifying its various subsegments.
Focuses on the key global Generic Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Generic Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Generic Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Drugs Consumption 2015-2025
2.1.2 Generic Drugs Consumption CAGR by Region
2.2 Generic Drugs Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.3 Generic Drugs Consumption by Type
2.3.1 Global Generic Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Generic Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Generic Drugs Sale Price by Type (2015-2020)
2.4 Generic Drugs Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Generic Drugs Consumption by Application
2.5.1 Global Generic Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Generic Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Generic Drugs Sale Price by Type (2015-2020)

3 Global Generic Drugs by Company
3.1 Global Generic Drugs Sales Market Share by Company
3.1.1 Global Generic Drugs Sales by Company (2018-2020)
3.1.2 Global Generic Drugs Sales Market Share by Company (2018-2020)
3.2 Global Generic Drugs Revenue Market Share by Company
3.2.1 Global Generic Drugs Revenue by Company (2018-2020)
3.2.2 Global Generic Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Generic Drugs Sale Price by Company
3.4 Global Generic Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Generic Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Generic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Generic Drugs by Regions
4.1 Generic Drugs by Regions
4.2 Americas Generic Drugs Consumption Growth
4.3 APAC Generic Drugs Consumption Growth
4.4 Europe Generic Drugs Consumption Growth
4.5 Middle East & Africa Generic Drugs Consumption Growth

5 Americas
5.1 Americas Generic Drugs Consumption by Countries
5.1.1 Americas Generic Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Generic Drugs Value by Countries (2015-2020)
5.2 Americas Generic Drugs Consumption by Type
5.3 Americas Generic Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Generic Drugs Consumption by Regions
6.1.1 APAC Generic Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Generic Drugs Value by Regions (2015-2020)
6.2 APAC Generic Drugs Consumption by Type
6.3 APAC Generic Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Generic Drugs by Countries
7.1.1 Europe Generic Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Generic Drugs Value by Countries (2015-2020)
7.2 Europe Generic Drugs Consumption by Type
7.3 Europe Generic Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Generic Drugs by Countries
8.1.1 Middle East & Africa Generic Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Generic Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Generic Drugs Consumption by Type
8.3 Middle East & Africa Generic Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Generic Drugs Distributors
10.3 Generic Drugs Customer

11 Global Generic Drugs Market Forecast
11.1 Global Generic Drugs Consumption Forecast (2021-2025)
11.2 Global Generic Drugs Forecast by Regions
11.2.1 Global Generic Drugs Forecast by Regions (2021-2025)
11.2.2 Global Generic Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Generic Drugs Forecast by Type
11.8 Global Generic Drugs Forecast by Application

12 Key Players Analysis
12.1 Teva
12.1.1 Company Information
12.1.2 Generic Drugs Product Offered
12.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Teva Latest Developments
12.2 Lupin
12.2.1 Company Information
12.2.2 Generic Drugs Product Offered
12.2.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lupin Latest Developments
12.3 Novartis - Sandoz
12.3.1 Company Information
12.3.2 Generic Drugs Product Offered
12.3.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis - Sandoz Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Company Information
12.4.2 Generic Drugs Product Offered
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Aspen
12.5.1 Company Information
12.5.2 Generic Drugs Product Offered
12.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Aspen Latest Developments
12.6 Mylan
12.6.1 Company Information
12.6.2 Generic Drugs Product Offered
12.6.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Sanofi
12.7.1 Company Information
12.7.2 Generic Drugs Product Offered
12.7.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sanofi Latest Developments
12.8 Fresenius Kabi
12.8.1 Company Information
12.8.2 Generic Drugs Product Offered
12.8.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Aurobindo
12.9.1 Company Information
12.9.2 Generic Drugs Product Offered
12.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Aurobindo Latest Developments
12.10 Pfizer (Hospira)
12.10.1 Company Information
12.10.2 Generic Drugs Product Offered
12.10.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer (Hospira) Latest Developments
12.11 Krka Group
12.11.1 Company Information
12.11.2 Generic Drugs Product Offered
12.11.3 Krka Group Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Krka Group Latest Developments
12.12 Valeant
12.12.1 Company Information
12.12.2 Generic Drugs Product Offered
12.12.3 Valeant Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Valeant Latest Developments
12.13 Nichi-Iko Pharmaceutical
12.13.1 Company Information
12.13.2 Generic Drugs Product Offered
12.13.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Nichi-Iko Pharmaceutical Latest Developments
12.14 Dr. Reddy's
12.14.1 Company Information
12.14.2 Generic Drugs Product Offered
12.14.3 Dr. Reddy's Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Dr. Reddy's Latest Developments
12.15 ENDO (Par Pharmaceutical)
12.15.1 Company Information
12.15.2 Generic Drugs Product Offered
12.15.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 ENDO (Par Pharmaceutical) Latest Developments
12.16 Cipla
12.16.1 Company Information
12.16.2 Generic Drugs Product Offered
12.16.3 Cipla Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Cipla Latest Developments
12.17 Hikma
12.17.1 Company Information
12.17.2 Generic Drugs Product Offered
12.17.3 Hikma Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Hikma Latest Developments
12.18 Stada Arzneimittel
12.18.1 Company Information
12.18.2 Generic Drugs Product Offered
12.18.3 Stada Arzneimittel Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Stada Arzneimittel Latest Developments
12.19 Apotex
12.19.1 Company Information
12.19.2 Generic Drugs Product Offered
12.19.3 Apotex Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Apotex Latest Developments
12.20 Zydus Cadila
12.20.1 Company Information
12.20.2 Generic Drugs Product Offered
12.20.3 Zydus Cadila Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Zydus Cadila Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Generic Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Simple Generic Drugs
Table 5. Major Players of Super Generic Drugs
Table 6. Major Players of Biosimilars
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Generic Drugs Consumption Market Share by Type (2015-2020)
Table 9. Global Generic Drugs Revenue by Type (2015-2020) ($ million)
Table 10. Global Generic Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Generic Drugs Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Generic Drugs Consumption Market Share by Application (2015-2020)
Table 14. Global Generic Drugs Value by Application (2015-2020)
Table 15. Global Generic Drugs Value Market Share by Application (2015-2020)
Table 16. Global Generic Drugs Sale Price by Application (2015-2020)
Table 17. Global Generic Drugs Sales by Company (2017-2019) (K MT)
Table 18. Global Generic Drugs Sales Market Share by Company (2017-2019)
Table 19. Global Generic Drugs Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Generic Drugs Revenue Market Share by Company (2017-2019)
Table 21. Global Generic Drugs Sale Price by Company (2017-2019)
Table 22. Global Generic Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Generic Drugs Products Offered
Table 24. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Generic Drugs Consumption by Regions 2015-2020 (K MT)
Table 26. Global Generic Drugs Consumption Market Share by Regions 2015-2020
Table 27. Global Generic Drugs Value by Regions 2015-2020 ($ Millions)
Table 28. Global Generic Drugs Value Market Share by Regions 2015-2020
Table 29. Americas Generic Drugs Consumption by Countries (2015-2020) (K MT)
Table 30. Americas Generic Drugs Consumption Market Share by Countries (2015-2020)
Table 31. Americas Generic Drugs Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Generic Drugs Value Market Share by Countries (2015-2020)
Table 33. Americas Generic Drugs Consumption by Type (2015-2020) (K MT)
Table 34. Americas Generic Drugs Consumption Market Share by Type (2015-2020)
Table 35. Americas Generic Drugs Consumption by Application (2015-2020) (K MT)
Table 36. Americas Generic Drugs Consumption Market Share by Application (2015-2020)
Table 37. APAC Generic Drugs Consumption by Countries (2015-2020) (K MT)
Table 38. APAC Generic Drugs Consumption Market Share by Countries (2015-2020)
Table 39. APAC Generic Drugs Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Generic Drugs Value Market Share by Regions (2015-2020)
Table 41. APAC Generic Drugs Consumption by Type (2015-2020) (K MT)
Table 42. APAC Generic Drugs Consumption Market Share by Type (2015-2020)
Table 43. APAC Generic Drugs Consumption by Application (2015-2020) (K MT)
Table 44. APAC Generic Drugs Consumption Market Share by Application (2015-2020)
Table 45. Europe Generic Drugs Consumption by Countries (2015-2020) (K MT)
Table 46. Europe Generic Drugs Consumption Market Share by Countries (2015-2020)
Table 47. Europe Generic Drugs Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Generic Drugs Value Market Share by Countries (2015-2020)
Table 49. Europe Generic Drugs Consumption by Type (2015-2020) (K MT)
Table 50. Europe Generic Drugs Consumption Market Share by Type (2015-2020)
Table 51. Europe Generic Drugs Consumption by Application (2015-2020) (K MT)
Table 52. Europe Generic Drugs Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Generic Drugs Consumption by Countries (2015-2020) (K MT)
Table 54. Middle East & Africa Generic Drugs Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Generic Drugs Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Generic Drugs Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Generic Drugs Consumption by Type (2015-2020) (K MT)
Table 58. Middle East & Africa Generic Drugs Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Generic Drugs Consumption by Application (2015-2020) (K MT)
Table 60. Middle East & Africa Generic Drugs Consumption Market Share by Application (2015-2020)
Table 61. Generic Drugs Distributors List
Table 62. Generic Drugs Customer List
Table 63. Global Generic Drugs Consumption Forecast by Countries (2021-2025) (K MT)
Table 64. Global Generic Drugs Consumption Market Forecast by Regions
Table 65. Global Generic Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Generic Drugs Value Market Share Forecast by Regions
Table 67. Global Generic Drugs Consumption Forecast by Type (2021-2025) (K MT)
Table 68. Global Generic Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Generic Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Generic Drugs Value Market Share Forecast by Type (2021-2025)
Table 71. Global Generic Drugs Consumption Forecast by Application (2021-2025) (K MT)
Table 72. Global Generic Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Generic Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Generic Drugs Value Market Share Forecast by Application (2021-2025)
Table 75. Teva Product Offered
Table 76. Teva Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. Teva Main Business
Table 78. Teva Latest Developments
Table 79. Teva Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Lupin Product Offered
Table 81. Lupin Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. Lupin Main Business
Table 83. Lupin Latest Developments
Table 84. Lupin Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis - Sandoz Product Offered
Table 86. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Novartis - Sandoz Main Business
Table 88. Novartis - Sandoz Latest Developments
Table 89. Novartis - Sandoz Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Sun Pharmaceutical Product Offered
Table 91. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. Sun Pharmaceutical Main Business
Table 93. Sun Pharmaceutical Latest Developments
Table 94. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Aspen Product Offered
Table 96. Aspen Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. Aspen Main Business
Table 98. Aspen Latest Developments
Table 99. Aspen Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Product Offered
Table 101. Mylan Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Mylan Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Product Offered
Table 106. Sanofi Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Sanofi Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 110. Fresenius Kabi Product Offered
Table 111. Fresenius Kabi Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Fresenius Kabi Main Business
Table 113. Fresenius Kabi Latest Developments
Table 114. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Aurobindo Product Offered
Table 116. Aurobindo Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 117. Aurobindo Main Business
Table 118. Aurobindo Latest Developments
Table 119. Aurobindo Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer (Hospira) Product Offered
Table 121. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 122. Pfizer (Hospira) Main Business
Table 123. Pfizer (Hospira) Latest Developments
Table 124. Pfizer (Hospira) Basic Information, Company Total Revenue (in $ million), Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Krka Group Product Offered
Table 126. Krka Group Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 127. Krka Group Main Business
Table 128. Krka Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Krka Group Latest Developments
Table 130. Valeant Product Offered
Table 131. Valeant Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 132. Valeant Main Business
Table 133. Valeant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Valeant Latest Developments
Table 135. Nichi-Iko Pharmaceutical Product Offered
Table 136. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 137. Nichi-Iko Pharmaceutical Main Business
Table 138. Nichi-Iko Pharmaceutical Latest Developments
Table 139. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Dr. Reddy's Product Offered
Table 141. Dr. Reddy's Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 142. Dr. Reddy's Main Business
Table 143. Dr. Reddy's Latest Developments
Table 144. Dr. Reddy's Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. ENDO (Par Pharmaceutical) Product Offered
Table 146. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 147. ENDO (Par Pharmaceutical) Main Business
Table 148. ENDO (Par Pharmaceutical) Latest Developments
Table 149. ENDO (Par Pharmaceutical) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Cipla Product Offered
Table 151. Cipla Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 152. Cipla Main Business
Table 153. Cipla Latest Developments
Table 154. Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Hikma Product Offered
Table 156. Hikma Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 157. Hikma Main Business
Table 158. Hikma Latest Developments
Table 159. Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. Stada Arzneimittel Product Offered
Table 161. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 162. Stada Arzneimittel Main Business
Table 163. Stada Arzneimittel Latest Developments
Table 164. Stada Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 165. Apotex Product Offered
Table 166. Apotex Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 167. Apotex Main Business
Table 168. Apotex Latest Developments
Table 169. Apotex Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 170. Zydus Cadila Product Offered
Table 171. Zydus Cadila Generic Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 172. Zydus Cadila Main Business
Table 173. Zydus Cadila Latest Developments
Table 174. Zydus Cadila Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Generic Drugs
Figure 2. Generic Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Generic Drugs Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Generic Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Simple Generic Drugs
Figure 7. Product Picture of Super Generic Drugs
Figure 8. Product Picture of Biosimilars
Figure 9. Global Generic Drugs Consumption Market Share by Type (2015-2020)
Figure 10. Global Generic Drugs Value Market Share by Type (2015-2020)
Figure 11. Generic Drugs Consumed in CNS
Figure 12. Global Generic Drugs Market: CNS (2015-2020) (K MT)
Figure 13. Global Generic Drugs Market: CNS (2015-2020) ($ Millions)
Figure 14. Generic Drugs Consumed in Cardiovascular
Figure 15. Global Generic Drugs Market: Cardiovascular (2015-2020) (K MT)
Figure 16. Global Generic Drugs Market: Cardiovascular (2015-2020) ($ Millions)
Figure 17. Generic Drugs Consumed in Genitourinary/Hormonal Drugs
Figure 18. Global Generic Drugs Market: Genitourinary/Hormonal Drugs (2015-2020) (K MT)
Figure 19. Global Generic Drugs Market: Genitourinary/Hormonal Drugs (2015-2020) ($ Millions)
Figure 20. Generic Drugs Consumed in Respiratory
Figure 21. Global Generic Drugs Market: Respiratory (2015-2020) (K MT)
Figure 22. Global Generic Drugs Market: Respiratory (2015-2020) ($ Millions)
Figure 23. Generic Drugs Consumed in Rheumatology
Figure 24. Global Generic Drugs Market: Rheumatology (2015-2020) (K MT)
Figure 25. Global Generic Drugs Market: Rheumatology (2015-2020) ($ Millions)
Figure 26. Generic Drugs Consumed in Diabetes
Figure 27. Generic Drugs Consumed in Oncology
Figure 28. Generic Drugs Consumed in Others
Figure 29. Global Generic Drugs Consumption Market Share by Application (2015-2020)
Figure 30. Global Generic Drugs Value Market Share by Application (2015-2020)
Figure 31. Global Generic Drugs Sales Market Share by Company in 2017
Figure 32. Global Generic Drugs Sales Market Share by Company in 2019
Figure 33. Global Generic Drugs Revenue Market Share by Company in 2017
Figure 34. Global Generic Drugs Revenue Market Share by Company in 2019
Figure 35. Global Generic Drugs Sale Price by Company in 2019
Figure 36. Global Generic Drugs Consumption Market Share by Regions 2015-2020
Figure 37. Global Generic Drugs Value Market Share by Regions 2015-2020
Figure 38. Americas Generic Drugs Consumption 2015-2020 (K MT)
Figure 39. Americas Generic Drugs Value 2015-2020 ($ Millions)
Figure 40. APAC Generic Drugs Consumption 2015-2020 (K MT)
Figure 41. APAC Generic Drugs Value 2015-2020 ($ Millions)
Figure 42. Europe Generic Drugs Consumption 2015-2020 (K MT)
Figure 43. Europe Generic Drugs Value 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Generic Drugs Consumption 2015-2020 (K MT)
Figure 45. Middle East & Africa Generic Drugs Value 2015-2020 ($ Millions)
Figure 46. Americas Generic Drugs Consumption Market Share by Countries in 2019
Figure 47. Americas Generic Drugs Value Market Share by Countries in 2019
Figure 48. Americas Generic Drugs Consumption Market Share by Type in 2019
Figure 49. Americas Generic Drugs Consumption Market Share by Application in 2019
Figure 50. United States Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 51. United States Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Canada Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 53. Canada Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Mexico Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 55. Mexico Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. APAC Generic Drugs Consumption Market Share by Countries in 2019
Figure 57. APAC Generic Drugs Value Market Share by Regions in 2019
Figure 58. APAC Generic Drugs Consumption Market Share by Type in 2019
Figure 59. APAC Generic Drugs Consumption Market Share by Application in 2019
Figure 60. China Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 61. China Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Japan Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 63. Japan Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. Korea Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 65. Korea Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. Southeast Asia Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 67. Southeast Asia Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. India Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 69. India Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Australia Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 71. Australia Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Europe Generic Drugs Consumption Market Share by Countries in 2019
Figure 73. Europe Generic Drugs Value Market Share by Countries in 2019
Figure 74. Europe Generic Drugs Consumption Market Share by Type in 2019
Figure 75. Europe Generic Drugs Consumption Market Share by Application in 2019
Figure 76. Germany Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 77. Germany Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. France Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 79. France Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. UK Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 81. UK Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. Italy Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 83. Italy Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Russia Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 85. Russia Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Middle East & Africa Generic Drugs Consumption Market Share by Countries in 2019
Figure 87. Middle East & Africa Generic Drugs Value Market Share by Countries in 2019
Figure 88. Middle East & Africa Generic Drugs Consumption Market Share by Type in 2019
Figure 89. Middle East & Africa Generic Drugs Consumption Market Share by Application in 2019
Figure 90. Egypt Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 91. Egypt Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. South Africa Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 93. South Africa Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 94. Israel Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 95. Israel Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 96. Turkey Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 97. Turkey Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 98. GCC Countries Generic Drugs Consumption Growth 2015-2020 (K MT)
Figure 99. GCC Countries Generic Drugs Value Growth 2015-2020 ($ Millions)
Figure 100. Global Generic Drugs Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 101. Global Generic Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 102. Americas Generic Drugs Consumption 2021-2025 (K MT)
Figure 103. Americas Generic Drugs Value 2021-2025 ($ Millions)
Figure 104. APAC Generic Drugs Consumption 2021-2025 (K MT)
Figure 105. APAC Generic Drugs Value 2021-2025 ($ Millions)
Figure 106. Europe Generic Drugs Consumption 2021-2025 (K MT)
Figure 107. Europe Generic Drugs Value 2021-2025 ($ Millions)
Figure 108. Middle East & Africa Generic Drugs Consumption 2021-2025 (K MT)
Figure 109. Middle East & Africa Generic Drugs Value 2021-2025 ($ Millions)
Figure 110. United States Generic Drugs Consumption 2021-2025 (K MT)
Figure 111. United States Generic Drugs Value 2021-2025 ($ Millions)
Figure 112. Canada Generic Drugs Consumption 2021-2025 (K MT)
Figure 113. Canada Generic Drugs Value 2021-2025 ($ Millions)
Figure 114. Mexico Generic Drugs Consumption 2021-2025 (K MT)
Figure 115. Mexico Generic Drugs Value 2021-2025 ($ Millions)
Figure 116. Brazil Generic Drugs Consumption 2021-2025 (K MT)
Figure 117. Brazil Generic Drugs Value 2021-2025 ($ Millions)
Figure 118. China Generic Drugs Consumption 2021-2025 (K MT)
Figure 119. China Generic Drugs Value 2021-2025 ($ Millions)
Figure 120. Japan Generic Drugs Consumption 2021-2025 (K MT)
Figure 121. Japan Generic Drugs Value 2021-2025 ($ Millions)
Figure 122. Korea Generic Drugs Consumption 2021-2025 (K MT)
Figure 123. Korea Generic Drugs Value 2021-2025 ($ Millions)
Figure 124. Southeast Asia Generic Drugs Consumption 2021-2025 (K MT)
Figure 125. Southeast Asia Generic Drugs Value 2021-2025 ($ Millions)
Figure 126. India Generic Drugs Consumption 2021-2025 (K MT)
Figure 127. India Generic Drugs Value 2021-2025 ($ Millions)
Figure 128. Australia Generic Drugs Consumption 2021-2025 (K MT)
Figure 129. Australia Generic Drugs Value 2021-2025 ($ Millions)
Figure 130. Germany Generic Drugs Consumption 2021-2025 (K MT)
Figure 131. Germany Generic Drugs Value 2021-2025 ($ Millions)
Figure 132. France Generic Drugs Consumption 2021-2025 (K MT)
Figure 133. France Generic Drugs Value 2021-2025 ($ Millions)
Figure 134. UK Generic Drugs Consumption 2021-2025 (K MT)
Figure 135. UK Generic Drugs Value 2021-2025 ($ Millions)
Figure 136. Italy Generic Drugs Consumption 2021-2025 (K MT)
Figure 137. Italy Generic Drugs Value 2021-2025 ($ Millions)
Figure 138. Russia Generic Drugs Consumption 2021-2025 (K MT)
Figure 139. Russia Generic Drugs Value 2021-2025 ($ Millions)
Figure 140. Spain Generic Drugs Consumption 2021-2025 (K MT)
Figure 141. Spain Generic Drugs Value 2021-2025 ($ Millions)
Figure 142. Egypt Generic Drugs Consumption 2021-2025 (K MT)
Figure 143. Egypt Generic Drugs Value 2021-2025 ($ Millions)
Figure 144. South Africa Generic Drugs Consumption 2021-2025 (K MT)
Figure 145. South Africa Generic Drugs Value 2021-2025 ($ Millions)
Figure 146. Israel Generic Drugs Consumption 2021-2025 (K MT)
Figure 147. Israel Generic Drugs Value 2021-2025 ($ Millions)
Figure 148. Turkey Generic Drugs Consumption 2021-2025 (K MT)
Figure 149. Turkey Generic Drugs Value 2021-2025 ($ Millions)
Figure 150. GCC Countries Generic Drugs Consumption 2021-2025 (K MT)
Figure 151. GCC Countries Generic Drugs Value 2021-2025 ($ Millions)
Figure 152. Teva Generic Drugs Market Share (2018-2020)
Figure 153. Lupin Generic Drugs Market Share (2018-2020)
Figure 154. Novartis - Sandoz Generic Drugs Market Share (2018-2020)
Figure 155. Sun Pharmaceutical Generic Drugs Market Share (2018-2020)
Figure 156. Aspen Generic Drugs Market Share (2018-2020)
Figure 157. Mylan Generic Drugs Market Share (2018-2020)
Figure 158. Sanofi Generic Drugs Market Share (2018-2020)
Figure 159. Fresenius Kabi Generic Drugs Market Share (2018-2020)
Figure 160. Aurobindo Generic Drugs Market Share (2018-2020)
Figure 161. Pfizer (Hospira) Generic Drugs Market Share (2018-2020)
Figure 162. Krka Group Generic Drugs Market Share (2018-2020)
Figure 163. Valeant Generic Drugs Market Share (2018-2020)
Figure 164. Nichi-Iko Pharmaceutical Generic Drugs Market Share (2018-2020)
Figure 165. Dr. Reddy's Generic Drugs Market Share (2018-2020)
Figure 166. ENDO (Par Pharmaceutical) Generic Drugs Market Share (2018-2020)
Figure 167. Cipla Generic Drugs Market Share (2018-2020)
Figure 168. Hikma Generic Drugs Market Share (2018-2020)
Figure 169. Stada Arzneimittel Generic Drugs Market Share (2018-2020)
Figure 170. Apotex Generic Drugs Market Share (2018-2020)
Figure 171. Zydus Cadila Generic Drugs Market Share (2018-2020)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3660
USD $5490
USD $7320
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.